LARA SHEKERDEMIAN to Vascular Resistance
This is a "connection" page, showing publications LARA SHEKERDEMIAN has written about Vascular Resistance.
Connection Strength
0.432
-
Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med. 2002 Apr 15; 165(8):1098-102.
Score: 0.185
-
The role of calcium channel blockers, steroids, anticoagulation, antiplatelet drugs, and endothelin receptor antagonists. Pediatr Crit Care Med. 2010 Mar; 11(2 Suppl):S46-52.
Score: 0.080
-
Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Med. 2003 Nov; 29(11):1996-2003.
Score: 0.051
-
The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease. J Thorac Cardiovasc Surg. 2002 Sep; 124(3):435-41.
Score: 0.048
-
Cardiovascular effects of intravenous midazolam after open heart surgery. Arch Dis Child. 1997 Jan; 76(1):57-61.
Score: 0.032
-
Urotensin-II contributes to pulmonary vasoconstriction in a perinatal model of persistent pulmonary hypertension of the newborn secondary to meconium aspiration syndrome. Pediatr Res. 2010 Feb; 67(2):150-7.
Score: 0.020
-
Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass. Crit Care Med. 2007 Jan; 35(1):252-9.
Score: 0.016